FDA
label_change
· 2018-02-21
FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
Summary
The FDA approved a supplemental application to Voltaren Arthritis Pain to update the product’s labeling for arthritis pain relief with diclofenac sodium topical…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)